
    
      This study is a Phase 4, multicenter, randomized, double-blind, placebo-controlled,
      parallel-group, efficacy and safety study of pegloticase with MTX vs. pegloticase with
      placebo for MTX in adult participants with uncontrolled gout.
    
  